The efficacy of incentive spirometry in patients with COPD

Basit Öğe Kaydı
dc.contributor.authorBasoglu, OK
dc.contributor.authorAtasever, A
dc.contributor.authorBacakoglu, F
dc.date.accessioned2019-10-27T18:58:05Z
dc.date.available2019-10-27T18:58:05Z
dc.date.issued2005
dc.departmentEge Üniversitesien_US
dc.description.abstractObjective: Although incentive spirometry (IS) is frequently used to prevent postoperative pulmonary complications, its efficacy in patients with COPD has not been documented. The aim of this study was to evaluate the effects of IS on pulmonary function tests, arterial blood gases, dyspnoea and health-related quality of life in patients hospitalized for COPD. Methodology: A total of 27 consecutive patients (mean age, 68.4 +/- 7.9 years; 26 males) admitted for COPD exacerbations were recruited for the study. In total, 15 (IS treatment group) used IS for 2 months, together with medical treatment. The remaining 12 (medical treatment group) were given only medical treatment. Pulmonary function and blood gases were measured. Assessment of dyspnoea by visual analogue scale (VAS) and quality of life using the St. George's Respiratory Questionnaire (SGRQ) were performed at admission and after 2 months of treatment. Results: The activity, impact and total scores for the SGRQ improved (all P <= 0.0001), PaCO2 values decreased (P = 0.02), PaO2 and PAO(2) values increased (P = 0.02 and P = 0.01, respectively) in the IS treatment group. However, there were no significant differences between the measurements made pretreatment and after 2 months of medical therapy in the medical treatment group, with regards to pulmonary function, blood gases, SGRQ scores and VAS. Conclusion: The use of IS appears to improve arterial blood gases and health-related quality of life in patients with COPD exacerbations, although it does not alter pulmonary function parameters.en_US
dc.identifier.doi10.1111/j.1440-1843.2005.00716.xen_US
dc.identifier.endpage353en_US
dc.identifier.issn1323-7799
dc.identifier.issn1440-1843
dc.identifier.issue3en_US
dc.identifier.pmid15955148en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage349en_US
dc.identifier.urihttps://doi.org/10.1111/j.1440-1843.2005.00716.x
dc.identifier.urihttps://hdl.handle.net/11454/37404
dc.identifier.volume10en_US
dc.identifier.wosWOS:000230551100012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofRespirologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectarterial blood gasesen_US
dc.subjectchronic obstructive pulmonary diseaseen_US
dc.subjecthealth-related quality of lifeen_US
dc.subjectincentive spirometryen_US
dc.subjectpulmonary function testen_US
dc.titleThe efficacy of incentive spirometry in patients with COPDen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu